Patents by Inventor Wolf R. Achterrath

Wolf R. Achterrath has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040229841
    Abstract: A combination therapy for treating cancer including administering at least one camptothecin derivative in conjunction with another anticancer agent. The combination therapy is preferably used as a first-line therapy for treating metastatic colorectal cancer and preferably involves administration of a combination of CPT-11, 5-fluorouracil and folinic acid, according to specific infusional treatment schedules which show therapeutic synergy in the treatment of cancer.
    Type: Application
    Filed: June 23, 2004
    Publication date: November 18, 2004
    Applicant: Aventis Pharma S.A.
    Inventor: Wolf R. Achterrath
  • Patent number: 6794370
    Abstract: A combination therapy for treating cancer including administering at least one camptothecin derivative in conjunction with another anticancer agent. The combination therapy is preferably used as a first-line therapy for treating metastatic colorectal cancer and preferably involves administration of a combination of CPT-11, 5-fluorouracil and folinic acid, according to specific infusional treatment schedules which show therapeutic synergy in the treatment of cancer.
    Type: Grant
    Filed: April 18, 2002
    Date of Patent: September 21, 2004
    Assignee: Aventis Pharma S.A.
    Inventor: Wolf R. Achterrath
  • Publication number: 20020111329
    Abstract: A combination therapy for treating cancer including administering at least one camptothecin derivative in conjunction with another anticancer agent. The combination therapy is preferably used as a first-line therapy for treating metastatic colorectal cancer and preferably involves administration of a combination of CPT-11, 5-fluorouracil and folinic acid, according to specific infusional treatment schedules which show therapeutic synergy in the treatment of cancer.
    Type: Application
    Filed: April 18, 2002
    Publication date: August 15, 2002
    Applicant: Aventis Pharma S.A.
    Inventor: Wolf R. Achterrath
  • Patent number: 6403569
    Abstract: A combination therapy for treating cancer including administering at least one camptothecin derivative in conjunction with another anticancer agent. The combination therapy is preferably used as a first-line therapy for treating metastatic colorectal cancer and preferably involves administration of a combination of CPT-11, 5-fluorouracil and folinic acid, according to specific infusional treatment schedules which show therapeutic synergy in the treatment of cancer.
    Type: Grant
    Filed: April 28, 2000
    Date of Patent: June 11, 2002
    Assignee: Aventis Pharma S.A.
    Inventor: Wolf R. Achterrath